Trials / Completed
CompletedNCT00210431
Post Marketing Surveillance Study of Dysport
A Post Marketing Surveillance Study of Dysport Formulated With a Batch of Bulk Active Substance From a New Primary Manufacturing Facility at the Centre for Applied Microbiology & Research (CAMR)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 783 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to provide further information regarding the risks and benefits of Dysport in marketed indications.
Conditions
- Blepharospasm
- Hemifacial Spasm
- Cervical Dystonia
- Spasmodic Torticollis
- Cerebral Palsy
- Muscle Spasticity
- Cerebrovascular Accident
- Equinus Deformity
- Facial Hyperdynamic Lines
Timeline
- Start date
- 2004-10-01
- Completion
- 2006-06-01
- First posted
- 2005-09-21
- Last updated
- 2020-03-31
Locations
36 sites across 3 countries: France, Germany, Russia
Source: ClinicalTrials.gov record NCT00210431. Inclusion in this directory is not an endorsement.